The FDA has rehired at least some workers tasked with releasing public records generated by the agency’s regulatory activities, two employees said. The recall reverses firings carried ...
Cytokinetics aims to compete with a Bristol Myers Squibb heart drug projected to become a blockbuster seller, and the company’s value proposition is that its drug candidate has a ...
It seems like the answer is now ‘yes’. EndPoints reports:
Stealth BioTherapeutics said the FDA would not meet its Tuesday deadline for approving or ...
Makary said in an interview at the Semafor World Economy Summit that he has “no plans to take action” to restrict mifepristone, the pill used in nearly two-thirds of abortions in the United ...
By KIM BELLARD
Perhaps you are the kind of person who acts as though that the food in the grocery store somehow magically appears, with no supply chain vulnerabilities along the way. You ...
Health and Human Services Secretary Robert F. Kennedy Jr. is continuing his life’s work of making public health more precarious as the Food and Drug Administration, which he oversees, ...
On Jan. 26, the FDA issued a CBD policy statement that reaffirmed its longstanding unwillingness or inability to regulate nonpharmaceutical CBD products. The announcement is riddled with ...
HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient ...
Dr. Mark A. Scialdone, a recognized expert in the field of organic chemistry who specializes in natural product chemistry, is an inventor of 37 issued US patents and the author of 17 ...